Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK1 | P23458 | 13/20 | 0.47 |
| ▸ | JAK2 | O60674 | 12/20 | 0.47 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.35 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.35 |
| ▸ | TYK2 | P29597 | 4/20 | 0.35 |
| ▸ | JAK3 | P52333 | 4/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | RAF1 | P04049 | 2/20 | 0.33 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.33 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | CCR5 | P51681 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2277557 | 0.86 | JAK1 (0.50) | JAK1JAK2TYK2JAK3CCR5 | |
| SCHEMBL2276023 | 0.84 | JAK1 (0.47) | JAK1JAK2TYK2JAK3HTT | |
| SCHEMBL2281787 | 0.83 | JAK1 (0.46) | JAK1JAK2TYK2JAK3 | |
| SCHEMBL2280657 | 0.82 | JAK2 (0.48) | JAK1JAK2TYK2JAK3HTT | |
| SCHEMBL2274417 | 0.82 | JAK1 (0.45) | JAK1JAK2PIK3C3TYK2JAK3 | |
| SCHEMBL2279892 | 0.81 | JAK2 (0.45) | JAK1JAK2TYK2JAK3 | |
| SCHEMBL2269216 | 0.81 | JAK1 (0.47) | JAK1JAK2PIK3C3TYK2JAK3 | |
| SCHEMBL2277347 | 0.81 | JAK1 (0.53) | JAK1JAK2TYK2JAK3HTT | |
| SCHEMBL2276746 | 0.80 | JAK2 (0.46) | JAK1JAK2TYK2JAK3HTT | |
| SCHEMBL2281422 | 0.80 | JAK1 (0.41) | JAK1JAK2PIK3C3TYK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |